Skip to main content
Fig. 6 | Renal Replacement Therapy

Fig. 6

From: In vitro effects of anti-MRSA agent adsorption onto the AN69ST hemofilter

Fig. 6

Clearance of anti-MRAS agents in the in vitro dialysis circuit model. Black area indicates clearance at 5 min. Shaded area indicates clearance at 60 min. The three samples on the right had molecular weights below 1000. After the fourth stage, the samples had molecular weights greater than 1000. The clearance of ABK at 60 min could not be calculated because the inlet and outlet ABK concentrations were below the measurement limits. ABK Arbekacin; LZD Linezolid; Standard-I, Meropenem; TEIC Teicoplanin; VCM Vancomycin; DAP Daptomycin; Standard-II, Cyanocobalamin. N.D.: Not detected

Back to article page